End Stage Renal Disease on Dialysis
Nephrology
Prevalence
230.0 / 100K
Incidence
40.0 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 4(1)
| Drug | Company |
|---|---|
| CHM intervention group | Valneva SE (VALN) |
Frequently asked questions
How many drugs are in development for End Stage Renal Disease on Dialysis?
BioSniper tracks 1 drug in development for End Stage Renal Disease on Dialysis across 1 company.
How many clinical trials target End Stage Renal Disease on Dialysis?
There are 3 clinical trials targeting End Stage Renal Disease on Dialysis tracked by BioSniper.
What is the prevalence of End Stage Renal Disease on Dialysis?
The estimated prevalence of End Stage Renal Disease on Dialysis is approximately 230.0 per 100,000 population.
Deep-dive into End Stage Renal Disease on Dialysis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis